Kidney Research UK is working in partnership with IN-PART’s Discover platform to find and fund new innovative partners and solutions. The purpose is to advance original research that will address the crucial challenges of kidney disease.
“We are delighted to launch the Kidney MedTech Competition as a new programme to accelerate research into kidney disease, so it makes a difference to kidney patients’ lives faster. By working with IN-PART on this exciting and innovative competition we will raise awareness and seek applicants from outside our traditional routes. At Kidney Research UK, we are committed to being ambitious and collaborating with others to ensure kidney research continues to grow,” commented Marc Stowell, executive director of development at Kidney Research UK.
The Kidney MedTech Competition aims to accelerate the development and availability of transformational technologies. It also aims to promote approaches to improve the prevention, protection and treatment of kidney disease. Kidney Research UK is seeking novel research that clearly outlines the positive impact on the lives of kidney patients, or how the project can support the prevention of kidney disease.
Applications from researchers should include preliminary pilot underpinning data, a short CV including publications and how the award would take the research to the next level and be submitted through IN-PART’s Discover platform, a bespoke industry scouting tools in use at more than 1,400 institutes worldwide that is free for academics and university research commercialisation teams to engage with the latest industrial requirements and challenges.
“We’re really excited to be working with Kidney Research UK on their MedTech competition to accelerate their patient-focused research strategy and to have our academic network engage with the campaign. It follows on from some great campaigns we’ve run with similar organisations such as Alzheimer’s Research UK and the Medicines Discovery Catapult to help provide a pathway for researchers to secure funding from research charities and consortia as well as traditional industry,” said Robin Knight, co-founder of IN-PART.
